BioWorld Asia

March 24, 2004

Researchers Find 'P-Loop' To Be Implicated In Cancer

Celltech Considering Partners For CDP 870 Co-Development

Heeding Recommendation, UK Starts Clinical Trials Network

FDA's Crawford Offers Israel Advice On U.S. Regulations

Other News To Note

Atugen Raises EUR5M As Fuel For SiRNA Drug Development

Following a change in strategy made public last month, Atugen AG secured €5 million in the first closing of its third round of financing. The company intends to use the new capital to accelerate its work on small interfering RNA therapeutics. (BioWorld International) Read More

Merits Of Stem Cells Questioned By EU Senior Advisory Committee

Today's news in brief

BioWorld

BioWorld briefs for July 7, 2026.

CINP 2026: Prenatal and adolescent stress shape brain vulnerability

BioWorld Science

Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

In the clinic for July 6, 2026

BioWorld

Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.